Ostra miękka mielopatia
Epidemiologia

Ostre wiotkie zapalenie rdzenia kręgowego (AFM) to rzadkie, ale poważne schorzenie neurologiczne, charakteryzujące się nagłym początkiem wiotkiego osłabienia kończyn oraz zmianami w istocie szarej rdzenia kręgowego widocznymi w MRI. Choroba dotyka głównie dzieci poniżej 18 roku życia (ponad 90% przypadków, mediana wieku około 6 lat) i może prowadzić do trwałego porażenia, a nawet śmierci. Epidemiologia AFM w USA wykazuje dwuletni cykl występowania z szczytami w latach 2014, 2016 i 2018 oraz sezonowość w okresie sierpień-listopad. W 2018 roku odnotowano rekordowe 238 potwierdzonych przypadków, jednak w latach 2019-2022 liczba przypadków spadła do 28-47 rocznie, mimo zwiększonej cyrkulacji enterowirusa D68 (EV-D68). Diagnostyka opiera się na nagłym wiotkim osłabieniu kończyn, zmianach w MRI ograniczonych do istoty szarej rdzenia oraz opcjonalnej pleocytozie w płynie mózgowo-rdzeniowym (≥5 komórek/mm³). Wykrywanie patogenów w CSF jest rzadkie, a PCR z płynów ustrojowych ma ograniczoną skuteczność.

Epidemiologia ostrego wiotkiego zapalenia rdzenia kręgowego (AFM)

Ostre wiotkie zapalenie rdzenia kręgowego (AFM) jest rzadkim, lecz poważnym schorzeniem neurologicznym, charakteryzującym się nagłym początkiem wiotkiego osłabienia kończyn i obecnością zmian w istocie szarej rdzenia kręgowego widocznych w obrazowaniu metodą rezonansu magnetycznego (MRI). Choroba ta dotyka głównie dzieci i może prowadzić do trwałego porażenia.12

Trendy czasowe i geograficzne

Centrum Kontroli i Prewencji Chorób (CDC) rozpoczęło monitorowanie AFM w sierpniu 2014 roku po zaobserwowaniu nietypowych skupisk przypadków choroby przypominającej polio u dzieci w Kolorado i Kansas.1 Od tego czasu do maja 2025 roku potwierdzono 774 przypadki AFM w Stanach Zjednoczonych, występujące w 49 stanach i Dystrykcie Kolumbii.1

Do 2019 roku zaobserwowano wyraźny wzorzec epidemiczny AFM, charakteryzujący się następującymi cechami:

  • Dwuletni (biennalny) cykl występowania, z wyraźnymi szczytami w latach 2014, 2016 i 201812
  • Sezonowość zachorowań – większość przypadków występuje późnym latem i wczesną jesienią (sierpień-listopad)12
  • Rekordowa liczba przypadków w 2018 roku – 238 potwierdzonych przypadków w USA12

Od 2019 roku zauważono zmianę w tym wzorcu. W latach 2019-2022 liczba przypadków AFM pozostawała niska (28-47 przypadków rocznie), mimo zwiększonego krążenia enterowirusa D68 (EV-D68) w USA w 2022 roku.12 Przyczyna tego zjawiska pozostaje niewyjaśniona i trudno jest przewidzieć, kiedy nastąpi kolejny wzrost liczby przypadków AFM.1

Przypadki AFM odnotowano również w wielu innych krajach, w tym w Kanadzie, Europie, Azji, Australii i Ameryce Południowej.1 W Kanadzie również zaobserwowano wzrost przypadków AFM w 2018 roku, z większością zachorowań występujących późnym latem i wczesną jesienią, co sugeruje podobny trend jak w USA.1

Charakterystyka demograficzna

AFM dotyka przede wszystkim dzieci – ponad 90% potwierdzonych przypadków występuje u osób poniżej 18 roku życia, przy medianie wieku wynoszącej około 6 lat.12 Dane epidemiologiczne wskazują na niewielką przewagę zachorowań u chłopców, natomiast nie zidentyfikowano wyraźnych predyspozycji rasowych czy etnicznych.1

Szacuje się, że częstość występowania AFM jest bardzo niska – mniej niż jeden przypadek na milion osób w Stanach Zjednoczonych rocznie, co czyni tę chorobę niezwykle rzadką, mimo obserwowanego wzrostu liczby przypadków.12

Czynniki ryzyka i powiązania z patogenami

Dokładna przyczyna AFM pozostaje nieznana, jednak istnieją silne dowody wskazujące na związek z infekcjami wirusowymi, szczególnie enterowirusami, w tym enterowirusem D68 (EV-D68).12

Obserwacje epidemiologiczne wykazały, że:

  • Wzrost przypadków AFM w 2014 roku zbiegł się z ogólnokrajowym wybuchem ciężkich chorób układu oddechowego spowodowanych przez EV-D681
  • W 2018 roku około 90% pacjentów z AFM zgłaszało objawy prodromalne w postaci infekcji dróg oddechowych lub gorączki przed wystąpieniem osłabienia kończyn1
  • W latach 2019-2020 odsetek pacjentów z poprzedzającą infekcją wirusową był niższy (57-63%)1
  • W przypadkach potwierdzonych AFM w Kanadzie enterowirus lub rinowirus/enterowirus był wykrywany w próbkach (innych niż płyn mózgowo-rdzeniowy) u połowy pacjentów1

Mimo intensywnych badań, CDC w większości przypadków nie zidentyfikowało patogenów w płynie mózgowo-rdzeniowym pacjentów z AFM.1 Wszystkie próbki kału od pacjentów z AFM były ujemne w kierunku wirusa polio.1

Interesującym zjawiskiem jest brak wzrostu przypadków AFM w 2022 roku mimo zwiększonej cyrkulacji EV-D68, co sugeruje, że związek między tymi dwoma czynnikami może być bardziej złożony niż początkowo sądzono.12

Nadzór nad AFM i systemy raportowania

Ze względu na poważny charakter choroby i jej potencjalne konsekwencje zdrowotne, AFM stało się przedmiotem intensywnego nadzoru epidemiologicznego zarówno na poziomie krajowym, jak i stanowym w USA oraz w innych krajach.1

Systemy nadzoru CDC

CDC prowadzi krajowy nadzór nad AFM od sierpnia 2014 roku, gdy zaobserwowano pierwszy wzrost liczby przypadków.1 W ramach tego nadzoru:

  • Departamenty zdrowia w USA przesyłają do CDC raporty o przypadkach ostrego wiotkiego osłabienia kończyn z jakimikolwiek zmianami w istocie szarej rdzenia kręgowego widocznymi w MRI1
  • Od 2015 roku stosowana jest definicja przypadku przyjęta przez Radę Epidemiologów Stanowych i Terytorialnych (CSTE), określająca AFM jako: ostre wystąpienie ogniskowego lub wiotkiego osłabienia kończyn oraz obraz MRI pokazujący zmiany w rdzeniu kręgowym ograniczone głównie do istoty szarej i obejmujące jeden lub więcej segmentów rdzenia, niezależnie od wieku1
  • Definicja przypadku AFM była aktualizowana w latach 2015, 2017, 2020 i 2021, aby zapewnić spójną i dokładną klasyfikację przypadków do celów nadzoru12

W 2018 roku CDC powołało grupę zadaniową składającą się z krajowych ekspertów, w tym zewnętrznych badaczy akademickich, aby opracować kompleksowy program badań nad AFM.1 W 2018 roku powstała również Grupa Robocza ds. AFM (AFM Working Group) w odpowiedzi na pojawienie się AFM jako choroby powodującej niepełnosprawność i stanowiącej znaczące zagrożenie dla zdrowia publicznego.1

Stanowe systemy nadzoru

Wiele stanów w USA prowadzi własne programy nadzoru nad AFM, współpracując z CDC w celu gromadzenia danych i klasyfikacji przypadków. Przykłady obejmują:

  • Minnesota Department of Health prowadzi nadzór nad ostrym wiotkim zapaleniem rdzenia/porażeniem, zgodnie z wymogami Communicable Disease Reporting Rule, Chapter 46051
  • Illinois Department of Public Health (IDPH) podkreśla znaczenie ciągłej czujności w identyfikowaniu przypadków AFM we wszystkich grupach wiekowych, niezależnie od statusu enterowirusa1
  • W stanie Waszyngton AFM jest zgłaszane do lokalnej jurysdykcji zdrowotnej w ciągu 24 godzin, a następnie do Departamentu Zdrowia w ciągu 7 dni od zakończenia dochodzenia w sprawie przypadku1

Chociaż AFM nie znajduje się na krajowej liście chorób podlegających obowiązkowemu zgłaszaniu, niektóre stany dobrowolnie zgłaszają przypadki AFM do CDC w celu dalszego dochodzenia.1 CDC finansuje departamenty zdrowia w celu wdrożenia programów zwiększających świadomość lekarzy na temat AFM.1

Kryteria diagnostyczne i zgłaszanie przypadków

Klinicyści powinni podejrzewać AFM u każdego pacjenta z ostrym wiotkim osłabieniem kończyn, szczególnie u dzieci z niedawną infekcją dróg oddechowych lub gorączką.1 Kryteria diagnostyczne obejmują:

  • Nagłe wystąpienie wiotkiego osłabienia kończyn (ogniskowego lub uogólnionego)1
  • Obraz MRI pokazujący zmiany w rdzeniu kręgowym ograniczone głównie do istoty szarej i obejmujące jeden lub więcej segmentów kręgosłupa1
  • Opcjonalnie: pleocytoza w płynie mózgowo-rdzeniowym (liczba białych krwinek w płynie mózgowo-rdzeniowym ≥5 komórek/mm³)1

Zaleca się, aby klinicyści zgłaszali wszystkich pacjentów podejrzewanych o AFM do lokalnych departamentów zdrowia, niezależnie od wyników badań laboratoryjnych czy obrazowania MRI.1 Jest to szczególnie ważne, ponieważ AFM jest rzadką chorobą, a gromadzenie informacji o wszystkich przypadkach pomaga lepiej zrozumieć jej spektrum, możliwe przyczyny, czynniki ryzyka i wyniki.1

Badania laboratoryjne i diagnostyka

W przypadku podejrzenia AFM zaleca się pobieranie próbek z wielu źródeł, w tym:

  • Płynu mózgowo-rdzeniowego (CSF)1
  • Surowicy1
  • Kału1
  • Wymazu z nosogardła lub jamy ustno-gardłowej1

Próbki powinny być pobierane jak najwcześniej, najlepiej w dniu wystąpienia osłabienia kończyn.1 Departamenty zdrowia mogą testować próbki w kierunku arbowirusów, pikornowirusów/enterowirusów i innych patogenów.1

Pomocne w diagnostyce może być również badanie odpowiedzi nerwowej, ważne jest jednak, aby testy były wykonywane w odpowiednim czasie (np. 7-10 dni po wystąpieniu osłabienia).1

Ostateczna klasyfikacja przypadków (potwierdzone, prawdopodobne, podejrzane, nie-przypadki) jest dokonywana przez zespół ekspertów neurologów w celach nadzoru, w oparciu o spójne i specyficzne kryteria, aby zapewnić, że śledzone przypadki są podobne.12

Wyzwania w nadzorze nad AFM

Nadzór nad AFM napotyka szereg wyzwań wynikających z rzadkości choroby, trudności diagnostycznych oraz ciągle ewoluującej wiedzy na jej temat.1

Wyzwania diagnostyczne

Diagnoza AFM może być trudna z kilku powodów:

  • AFM może być mylone z innymi schorzeniami neurologicznymi, takimi jak zespół Guillaina-Barrégo1
  • Badanie MRI ma kluczowe znaczenie dla prawidłowej diagnozy – MRI w AFM wykazuje zmiany w pniu mózgu i rdzeniu kręgowym z przewagą zmian w istocie szarej, podczas gdy w zespole Guillaina-Barrégo MRI wykazuje nieprawidłowości korzeni brzusznych bez zmian w rdzeniu kręgowym czy pniu mózgu1
  • Obecne metody wykrywania genomów wirusowych wyłącznie za pomocą PCR przy użyciu komórek izolowanych z płynów ustrojowych wydają się być suboptymalne lub nieefektywne1

Brak swoistych testów diagnostycznych oraz trudności w izolacji czynnika przyczynowego komplikują proces diagnostyczny i nadzór nad chorobą.1

Znaczenie nadzoru

Pomimo wyzwań, nadzór nad AFM jest niezwykle ważny z kilku powodów:

  • Identyfikacja przypadków AFM i ustalenie wyjściowej częstości występowania oraz obciążenia tą chorobą1
  • Pomoc w identyfikacji przyczyn AFM w Stanach Zjednoczonych1
  • Zrozumienie wpływu AFM na wszystkie grupy wiekowe1
  • Monitorowanie trendów i wykrywanie ognisk choroby1
  • Wykluczenie związku AFM ze szczepionką przeciwko polio w krajach wolnych od polio, zgodnie z zaleceniami Światowej Organizacji Zdrowia12

Ciągły nadzór nad AFM w Georgii jest niezbędny do określenia obciążenia tym zespołem i ustalenia wyjściowej częstości występowania.1 Podobnie, inne stany kontynuują nadzór w celu lepszego zrozumienia epidemiologii AFM.1

Systemy wczesnego ostrzegania

Opracowywane są również systemy wczesnego ostrzegania, które mogą pomóc w przewidywaniu wzrostu przypadków AFM. Na przykład:

  • Nadzór syndromiczny nad astmą w Colorado jest wykorzystywany do monitorowania krążenia EV-D68, które może poprzedzać przypadki AFM1
  • Model ten wygenerował sygnał alarmowy tylko podczas zwiększonego krążenia EV-D68, a nie podczas wzrostu COVID, RSV czy grypy1
  • Potwierdzenie to pozwoliło szpitalowi dziecięcemu w Colorado aktywować plan gotowości, w tym zwiększenie harmonogramów personelu, zabezpieczenie łańcucha dostaw leków na astmę i ostrzeżenie lekarzy o możliwości wystąpienia przypadków AFM1

W przeszłości wzrost liczby przypadków choroby układu oddechowego związanej z EV-D68 poprzedzał przypadki AFM o około 2 tygodnie, co podkreśla znaczenie zwiększonej czujności na możliwy wzrost zarówno choroby układu oddechowego związanej z EV-D68, jak i AFM.12

Perspektywy i dalsze kierunki

Pomimo znacznych postępów w zrozumieniu epidemiologii AFM od czasu rozpoczęcia nadzoru w 2014 roku, wiele pytań pozostaje bez odpowiedzi.12

Nierozwiązane pytania

Kluczowe nierozwiązane pytania dotyczące AFM obejmują:

  • Dlaczego zwiększona cyrkulacja EV-D68 w 2022 roku nie była związana ze wzrostem liczby przypadków AFM12
  • Kiedy nastąpi kolejny wzrost liczby przypadków AFM1
  • Dlaczego tylko niewielka liczba osób rozwija AFM po infekcji dróg oddechowych1
  • Kim są osoby o podwyższonym ryzyku rozwoju AFM i jakie są przyczyny tego podwyższonego ryzyka1
  • Jakie są długoterminowe skutki AFM1

Odpowiedzi na te pytania będą wymagały dalszych badań i ciągłego nadzoru epidemiologicznego.1

Potrzeby badawcze

Aby lepiej zrozumieć AFM, potrzebne są następujące działania:

  • Pilne biomedyczne badania laboratoryjne w celu dokładnego określenia podstawowych przyczyn i szczegółów mechanistycznych AFM1
  • Zaprojektowanie nowatorskich alternatywnych lub zdegenerowanych starterów do amplifikacji nieznanych sekwencji z wariantów mutacji związanych z patogenezą AFM1
  • Kontynuacja monitorowania i badania przypadków AFM, czynników ryzyka i możliwych przyczyn tej choroby1
  • Podnoszenie świadomości i edukowanie społeczności na temat AFM w celu zwiększenia gotowości na potencjalne nadchodzące wybuchy epidemii1

Poważność choroby oraz brak jasnej wiedzy na temat etiologii podkreślają potrzebę lepszego zrozumienia epidemiologii AFM w celu zidentyfikowania środków zapobiegawczych i zarządzania pacjentami.1

Znaczenie kliniczne

Pomimo tego, że AFM jest rzadką chorobą, jej potencjalne konsekwencje są poważne:1

  • AFM może prowadzić do śmierci, a wśród dzieci, które przeżyją, mniej niż 10% osiąga pełne wyzdrowienie1
  • Większość pacjentów z rozpoznaniem AFM jest hospitalizowana, a spośród hospitalizowanych 30% wymaga intubacji1
  • Zgony związane z AFM są spowodowane zajęciem układu oddechowego i powikłaniami1
  • Przy odpowiednim rozpoznaniu i leczeniu wspomagającym można uniknąć śmiertelności1

CDC nadal zachęca lekarzy do zachowania czujności w przypadku AFM u ich pacjentów i do przekazywania informacji o podejrzanych przypadkach do swoich departamentów zdrowia, mimo że AFM pozostaje bardzo rzadką chorobą (mniej niż jeden przypadek na milion).1

Osiągnięcie właściwej diagnozy pozwala lekarzom medycyny ratunkowej na dokładniejszą komunikację z zaniepokojonymi rodzicami, dostarczając im prawidłowych informacji na temat leczenia i przebiegu choroby.1

Kolejne rozdziały

Zapraszamy do dalszego czytania naszego leksykonu.

Wybierz kolejny rozdział z menu poniżej, aby otworzyć nową podstronę kompedium wiedzy i uzyskać szczegółowe informację o leku, substancji lub chorobie.

  1. 17.04.2026
  2. www.leksykon.com.pl

Materiały źródłowe

  • #1 Surveillance for Acute Flaccid Myelitis – United States, 2018-2022 – PubMed
    https://pubmed.ncbi.nlm.nih.gov/38300829/
    Acute flaccid myelitis (AFM) is a serious neurologic condition primarily affecting children; AFM can cause acute respiratory failure and permanent paralysis. AFM is a rare but known complication of various viral infections, particularly those of enteroviruses (EVs). Increases in AFM cases during 2014, 2016, and 2018 were associated with EV-D68 infection. This report examines trends in confirmed AFM cases during 2018-2022 and patients’ clinical and laboratory characteristics. The number of AFM cases was low during 2019-2022 (28-47 cases per year); the number of cases remained low in 2022 despite evidence of increased EV-D68 circulation in the United States. Compared with cases during the most recent peak year (2018), fewer cases during 2019-2021 had upper limb involvement, prodromal respiratory or febrile illness, or cerebrospinal fluid pleocytosis, and more were associated with lower limb involvement. It is unclear why EV-D68 circulation in 2022 was not associated with an increase in AFM cases or when the next increase in AFM cases will occur. Nonetheless, clinicians should continue to suspect AFM in any child with acute flaccid limb weakness, especially those with a recent respiratory or febrile illness. […] National surveillance for acute flaccid myelitis – United States, 2018-2020. […] Epidemiology of acute flaccid myelitis in children in the Netherlands, 2014 to 2019. […] Enterovirus infection and acute flaccid myelitis.
  • #1 AFM Statistics | Georgia Department of Public Health
    https://dph.georgia.gov/afm-statistics
    The Centers for Disease Control and Prevention (CDC) has requested states provide information on suspect Acute Flaccid Myelitis (AFM) cases since the fall of 2014, when clusters of pediatric cases with AFM were identified in Colorado and Kansas. States have been reporting suspect AFM cases to CDC and submitting specimens for testing since the fall of 2014. […] Most cases occurred between August and November. CDC thinks viruses, including enteroviruses, likely play a role in AFM in the United States. Most reported cases in the U.S. have been in children, but people of any age can get AFM. […] As of December 2, 2024, In the United States there have been 15 confirmed cases out of 30 patients under investigation (PUIs) in 2024 and 18 confirmed cases out of 40 PUIs in 2023. There have been a total of 760 confirmed cases since CDC began tracking AFM in August of 2014. […] From August 2014 to December 2, 2024, 760 confirmed AFM cases were reported from 49 states and the District of Columbia. […] Continuing routine surveillance for AFM in Georgia is necessary to determine the burden of this syndrome and establish baseline incidence.
  • #1 AFM Cases & Outbreaks | Acute Flaccid Myelitis (AFM) | CDC
    https://www.cdc.gov/acute-flaccid-myelitis/cases/index.html
    As of May 5, 2025, there have been 774 confirmed cases since CDC began tracking AFM in August of 2014. […] Cases of AFM have occurred in 49 states and the District of Columbia. […] Most patients developed AFM between August and November, with increases in AFM cases in 2014, 2016, and 2018. […] Confirmed AFM cases by CDC from August 2014 through May 5, 2025. Case counts are subject to change. […] The data shown from August 2015 to present are based on the AFM case definition adopted by the Council of State and Territorial Epidemiologists (CSTE): acute onset of focal or flaccid limb weakness and an MRI showing spinal cord lesion largely restricted to gray matter and spanning one or more spinal segments, regardless of age.
  • #1 Surveillance for Acute Flaccid Myelitis ― United States, 2018–2022 | MMWR
    https://www.cdc.gov/mmwr/volumes/73/wr/mm7304a1.htm
    Acute flaccid myelitis (AFM) is a serious neurologic condition that has been associated with enterovirus-D68 (EV-D68) infection. Biannual increases in cases were observed in the United States during 2014, 2016, and 2018. […] The number of AFM cases has remained low since 2018, including during 2022, when an increase in EV-D68 respiratory disease was observed. […] Why increased EV-D68 circulation in 2022 was not associated with an increase in AFM cases or when AFM will peak again is unknown. […] The number of AFM cases was low during 2019-2022 (2847 cases per year); the number of cases remained low in 2022 despite evidence of increased EV-D68 circulation in the United States. […] It is unclear why EV-D68 circulation in 2022 was not associated with an increase in AFM cases or when the next increase in AFM cases will occur. […] Current trends do not indicate when the next increase of AFM might be expected.
  • #1 About AFM | Acute Flaccid Myelitis Working Group
    https://acuteflaccidmyelitis.org/about-afm/
    AFM is a neurological condition characterized by a rapid onset of flaccid muscle weakness, with associated abnormalities on the radiological imaging of the spinal cord (MRI). […] Although sporadic cases of non-polio infantile paralysis have been reported in the medical literature in the past, it was not until 2012 in California and 2014 in Colorado when unusual but significant clusters of pediatric patients with a polio-like illness started rising quickly in the USA. This prompted the CDC to begin collecting surveillance data on the disease we now call AFM. Between August 2014 and June 2020, there have been 626 confirmed cases across the USA. AFM cases have also been reported in multiple regions worldwide including Canada, Europe, Asia, Australia, and South America. […] Thanks to the epidemiological surveillance efforts, it was noted that this disease usually follows a particular seasonal biennial pattern, with notable peaks of cases between August and October every 2 years (2014, 2016, 2018, and maybe 2020!). […] Over 90% of cases of AFM occur in children (median age of 6 years), and no racial or ethnic predispositions have been clearly identified. A slight predisposition to males has been reported.
  • #1 Acute flaccid myelitis (AFM) in Canada, 2018 to 2019, CCDR 46(10) – Canada.ca
    https://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2020-46/issue-10-october-1-2020/acute-flaccid-myelitis.html
    This study describes the preliminary analysis of AFM in Canada for the years 2018 and 2019, using data from the Canadian Acute Flaccid Paralysis Surveillance System (CAFPSS). […] A small proportion (10%) of the cases reported from 2018 and 2019 met the 2018 CDC case definition for confirmed AFM, with the majority having onset of paralysis in the late summer and early fall of 2018. […] This coincides temporally with the cyclical increase in AFM cases observed in the United States, suggesting that a similar trend might be occurring in Canada. […] Enterovirus or rhinovirus/enterovirus was detected in non-cerebrospinal fluid specimens of half of the confirmed AFM cases, a greater proportion than seen in any of the other AFM categories.
  • #1 Acute Flaccid Myelitis | Orange County California – Health Care Agency
    https://www.ochealthinfo.com/page/acute-flaccid-myelitis
    Increases in AFM have been reported from several different areas of the U.S. in 2018. CDC continues to actively investigate the AFM cases, monitor disease activity and test specimens. […] AFM is a very rare condition with less than one case in a million people in the United States reported every year, even with the recent increase. […] Suspect cases should be reported to Orange County Epidemiology at 714-834-8180 or fax records to 714-560-4050. Specimens on suspect AFM cases that meet criteria may be submitted for testing for specific infectious etiologies through Orange County Public Health.
  • #1 Acute Flaccid Myelitis | AFM Surveillance | CDC
    http://medbox.iiab.me/modules/en-cdc/www.cdc.gov/acute-flaccid-myelitis/afm-surveillance.html
    CDC is concerned about AFM, a serious illness that we do not know all the cause of or how to prevent. […] CDC is actively investigating AFM cases. In 2016, 144 people in 37 states and DC were confirmed to have AFM. […] Even with an increase in cases in 2016, AFM remains a very rare disease (less than one in a million). […] Since August 2014, CDC has been made aware of an increased number of people across the United States with AFM for which no cause could be found. […] The increase in AFM cases in 2014 coincided with a national outbreak of severe respiratory illness among people caused by enterovirus D68 (EV-D68). […] Despite extensive testing, CDC does not yet know the cause of these AFM cases. […] CDC is actively investigating AFM cases and monitoring disease activity. […] CDC activities include: urging healthcare providers to be vigilant for AFM among their patients, and to send information about suspected cases to their health departments. […] CDC actively investigates the AFM cases, risk factors, and possible causes of this illness.
  • #1 Acute Flaccid Myelitis | PM&R KnowledgeNow
    https://now.aapmr.org/acute-flaccid-myelitis/
    AFM cases curiously were low during the 2019-2022 time frame, notably low despite growing circulation of EV-D68. […] There are no cases reported of recurrence after initial diagnosis. […] A preceding viral illness was reported in 90% of patients in 2018 and prior. Proceeding viral illness was present in 57% and 63% in 2019 and 2020 respectively. […] Suspected cases should be reported to CDC. […] Difficulty in performing placebo-controlled trials limits the ability to definitively identify treatment options. […] Centers for Disease Control and Prevention AFM Investigation 2019.
  • #1 Airborne and Direct Contact Diseases – Group B Strep – Disease Surveillance Epidemiology Program – MeCDC; DHHS Maine
    https://www.maine.gov/dhhs/mecdc/infectious-disease/epi/airborne/acute-flaccid-myelitis.shtml
    Acute flaccid myelitis (AFM) is a rare but serious condition. It affects the nervous system causing the muscles and reflexes in the body to become weak. Most AFM cases occur in late summer and early fall between August and October. More than 90% of cases have been in young children. […] Clinicians should report all patients suspected to have AFM, especially after respiratory illness or fever to Maine Center for Disease Control and Prevention (Maine CDC) as soon as possible. […] Most patients with AFM had a mild respiratory illness or fever with a viral infection before they developed AFM. […] It is unknown why a small number of people develop AFM after a respiratory illness. […] Federal CDC has tested many specimens from AFM in attempt to determine the cause of AFM. For most cases, federal CDC did not find any pathogens in the spinal fluid. […] All stool samples from AFM patients tested negative for poliovirus.
  • #1 Acute flaccid myelitis (AFM) in Canada, 2018 to 2019, CCDR 46(10) – Canada.ca
    https://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2020-46/issue-10-october-1-2020/acute-flaccid-myelitis.html
    Starting in 2014, biennial clusters of acute flaccid myelitis (AFM), frequently described as polio-like illness, have been reported across the United States and elsewhere, often linked to enteroviruses. […] To assess AFM trends in Canada, we reviewed the Canadian Acute Flaccid Paralysis Surveillance System (CAFPSS) for cases reported during the 2018 and 2019 calendar years that meet the Centers for Disease Control and Prevention case definitions for AFM. […] At the time of writing this report, 2020 AFM data were not yet available; it is unknown if a spike in AFM cases will be seen in 2020. […] The seriousness of the condition as well as the lack of clear knowledge about the etiology of the disease underscore the need to better understand the epidemiology of AFM to further identify prevention and patient management measures.
  • #1 CDC: Biennial Surge in Acute Flaccid Myelitis Has Come to a Halt | MedPage Today
    https://www.medpagetoday.com/infectiousdisease/generalinfectiousdisease/108563
    Acute flaccid myelitis (AFM) cases remained low in 2022, despite increased circulation of the enterovirus D68 (EV-D68) in the U.S., according to an analysis of CDC data. […] AFM cases ranged from 28 to 47 per year from 2019 to 2022 — far lower than the 238 confirmed cases in 2018, Sarah Kidd, MD, from the CDC’s National Center for Immunization and Respiratory Diseases in Atlanta, and colleagues reported in Morbidity and Mortality Weekly Report. […] As part of national surveillance of AFM, which began in 2014, U.S. health departments have submitted case reports of acute flaccid limb weakness with any spinal cord gray matter lesion on MRI to the CDC. […] AFM cases have tended to peak in even-numbered years, due to biennial outbreaks of EV-D68. […] It is unclear why EV-D68 circulation in 2022 was not associated with an increase in AFM cases or when the next increase in AFM cases will occur, wrote Kidd and co-authors.
  • #1 Acute Flaccid Myelitis Data | Texas DSHS
    https://www.dshs.texas.gov/vaccine-preventable-diseases/vaccine-preventable-disease-conditions/acute-flaccid-myelitis-afm/acute-flaccid-myelitis-data
    Acute Flaccid Myelitis (AFM) Cases and Incidence Rates in Texas, 2010-2020 […] Note: There are no AFM cases prior to 2014 since AFM was not first identified until 2014. The case definition for AFM changed in 2015, 2017, 2020 and 2021.
  • #1 Acute Flaccid Myelitis: How CDC Assists States in Investigating Emerging Diseases – EveryCRSReport.com
    https://www.everycrsreport.com/reports/IN10994.html
    Concern has grown over the recent increase in Acute Flaccid Myelitis (AFM) cases around the country. According to the Centers for Disease Control and Prevention (CDC), AFM is a rare condition with no specific treatment that mostly impacts children. As of November 9, CDC has confirmed 90 cases of AFM in 27 states thus far in 2018. CDC began tracking AFM in August 2014, when there was a sudden increase in cases in the United States. Though cases have increased, AFM remains a rare disease. CDC estimates that fewer than one to two in a million children in the United States get AFM each year. […] AFM is not on the national notifiable conditions list; however, some states may voluntarily report AFM cases to CDC for further investigation. CDC has funded health departments to implement physician awareness programs on AFM. […] CDC states that evidence suggests a viral cause for AFM. On November 13, CDC reported that it has established a task force of national experts, including external academic researchers, to develop a comprehensive research agenda on AFM.
  • #1 About AFMWG | Acute Flaccid Myelitis Working Group
    https://acuteflaccidmyelitis.org/
    The AFM Working Group was established in North America in September 2018 in response to the emergence of AFM as a disabling disease representing a significant public health threat. […] Develop and share up to date information of the epidemiology, natural history, disease mechanisms, and clinical aspects of AFM. […] Raise awareness and educate the community on AFM to increase our preparedness for potential upcoming outbreaks. […] Preserve partnership and frequent communication with the Centers for disease control AFM Surveillance Team and the National Institutes of Health.
  • #1 Surveillance for Acute Flaccid Myelitis (AFM): Information for Health Professionals – MN Dept. of Health
    https://www.health.state.mn.us/diseases/afm/hcp.html
    The Minnesota Department of Health is conducting surveillance for acute flaccid myelitis/paralysis. […] Reporting of patients meeting the criteria is consistent with a case of Unexplained Critical Illness as per the Communicable Disease Reporting Rule, Chapter 4605. […] Based on clinical presentation, MDH may test for arboviruses, picornaviruses/enteroviruses, and other pathogens.
  • #1 Acute Flaccid Myelitis (AFM)
    https://dph.illinois.gov/topics-services/diseases-and-conditions/diseases-a-z-list/afm.html
    As of May 1, 2025, IDPH is reporting the following number of patients under investigation during the given year and the number of cases that are confirmed, probable, and not cases according to the Centers for Disease Control and Prevention (CDC) after review of the case information provided. IDPH is continually working with the health care providers and local health departments to collect necessary information to send to the CDC for AFM case classification. […] The Illinois Department of Public Health (IDPH) is re-emphasizing the importance of continued vigilance in identifying cases of AFM among all age groups, irrespective of enterovirus status. Reporting of these cases will help public health officials monitor for increases in this illness and better understand potential causes, risk factors, and preventive measures or therapies. We are asking all clinicians to report AFM cases to the local health department, governing the jurisdiction where the patient lives.
  • #1 Acute Flaccid Myelitis (AFM) | Washington State Department of Health
    https://doh.wa.gov/public-health-provider-resources/notifiable-conditions/afm
    AFM is considered a medical emergency as some patients can experience rapid respiratory failure and may require ventilator support. […] To identify cases of AFM and establish an incidence baseline and burden of the condition in Washington State. […] To help identify causes of AFM in the United States. […] To understand the impact of AFM among all age groups. […] Health care providers and Health care facilities: notifiable to local health jurisdiction within 24 hours. […] Local health jurisdictions: notifiable to the Washington Department of Health (DOH) Office of Communicable Disease Epidemiology (CDE) within 7 days of case investigation completion or summary information required within 21 days.
  • #1
    https://hip.phila.gov/disease-control/diseasesconditions/acute-flaccid-myelitis/
    Report any illness to PDPH that meets all of the current Council of State and Territorial Epidemiologists (CSTE) case definition criteria: A person with acute onset of focal limb weakness, AND A magnetic resonance image showing a spinal cord lesion largely restricted to gray matter*+, and spanning one or more vertebral segments OR Cerebrospinal fluid (CSF) with pleocytosis (CSF white blood cell count 5 cells/mm3); CSF protein may or may not be elevated […] Providers should also remember to routinely report any patient (suspected or confirmed) with the following conditions and infections that cause neurologic symptoms to PDPH: Encephalitis or meningitis regardless of etiology, Guillain-Barr syndrome, West Nile virus and other arboviral infections, Lyme disease, Varicella and herpes zoster.
  • #1 Acute Flaccid Myelitis Reporting | Texas DSHS
    https://www.dshs.texas.gov/vaccine-preventable-diseases/vaccine-preventable-disease-conditions/acute-flaccid-myelitis-afm/acute-flaccid-myelitis-reporting
    Acute flaccid myelitis (AFM) is not nationally notifiable; CDC relies on clinician recognition and health department reporting of suspected AFM cases to learn more about AFM and what causes it. Texas is participating in enhanced AFM surveillance. […] Clinicians should continue to be vigilant and send all information about patients that meet the clinical criteria (sudden onset of flaccid limb weakness) for AFM to their state or local health department. Since AFM is a relatively new condition, we need information on all patients to help us better understand the spectrum of AFM illness, all possible causes, risk factors, and outcomes for this condition. […] Clinicians should send information on patients who meet the clinical criteria regardless of any laboratory results or MRI findings. […] Information should be sent to the local or state public health department regardless of any laboratory and MRI results. […] Per CDC request please submit all above requested information to your local health department.
  • #1
    https://content.govdelivery.com/accounts/WIDHS/bulletins/3306905
    The Wisconsin Department of Health Services, Division of Public Health (DPH) has identified 17 confirmed and 6 probable case of AFM in Wisconsin residents since 2014 and will continue to investigate other potential cases. […] AFM is a reportable condition in Wisconsin. Report all cases of acute flaccid limb weakness to the Wisconsin Division of Public Health (DPH) within 24 hours (after hours reporting not required) by calling the Bureau of Communicable Diseases (BCD) at 608-267-9003. […] Strongly consider AFM in patients with acute flaccid limb weakness, especially after respiratory illness or fever, and between the months of August and November 2022. […] Collect specimens from multiple sources (cerebrospinal fluid [CSF], serum, stool, and a nasopharyngeal [NP] or oropharyngeal [OP] swab) from patients presenting with possible AFM as early as possible and preferably on the day of onset of limb weakness.
  • #1 NC DPH: Acute Flaccid Myelitis (AFM)
    https://epi.dph.ncdhhs.gov/cd/diseases/afm.html
    Acute flaccid myelitis (AFM) is a condition that affects the nervous system, specifically the spinal cord, which can result from a variety of causes including viral infections. […] CDC: AFM Surveillance […] Testing nerve response can also be helpful in supporting a diagnosis of AFM; it is important that the tests are performed at the appropriate time (e.g., 7-10 days after onset of weakness) to be helpful.
  • #1 Health Alert: Acute Flaccid Myelitis
    https://www.snohd.org/CivicSend/ViewMessage/message/183540
    From January 1, 2022, through September 6, 2022, CDC has received 35 reports of suspected acute flaccid myelitis (AFM) in persons from 17 U.S. states; 13 have been classified as confirmed cases of AFM, 2 as probable, 6 as not cases, 1 as suspect, and 13 are waiting information or classification. […] Reports from possible cases of AFM will be submitted to CDC as part of surveillance to help track AFM, understand the spectrum of the disease, detect outbreaks, and inform research. […] Case classification status (i.e., confirmed, probable, suspect, not a case) is for surveillance purposes and based on consistent and specific criteria to ensure cases being tracked are similar.
  • #1 :: JCN :: Journal of Clinical Neurology
    https://thejcn.com/DOIx.php?id=10.3988/jcn.2020.16.3.376
    Acute flaccid myelitis (AFM) is a sudden-onset polio-like neuromuscular disability found commonly in young children. […] There is an increasing incidence of confirmed AFM cases in the USA and other countries in recent years, and in association with nonpolio enterovirus infection. […] The incidence of AFM was first identified in the USA in 2014, and has steadily increased in 2019 to become recognized as a serious threat to public health. […] Up to 2019, there were 607 confirmed cases of AFM recorded out of many hundreds of reports from several states, with the incidence peaking in 2018. […] According to the World Health Organization, the surveillance of AFM cases is critically important to rule out the association of AFM with the polio vaccine in polio-free countries. […] It might be necessary to design novel alternative or degenerate primers to amplify unknown sequences from mutant variants associated with AFM pathogenesis.
  • #1 Acute Flaccid Myelitis – JETem
    https://jetem.org/acute-flaccid-myelitis/
    AFM is a disease that occurs in a biennial pattern and needs to be recognized and reported appropriately. […] AFM MRI abnormalities demonstrate brainstem and spinal cord lesions with a predominance of gray matter affected while a GBS MRI demonstrates ventral root abnormalities without any spinal cord or brainstem lesions. Without the MRI results, a patient may be assigned the incorrect diagnosis upon admission. […] Reaching the appropriate diagnosis allows the emergency medicine physician to communicate more accurately with worried parents, providing them with correct information on treatment and progression of the disease.
  • #1 :: JCN :: Journal of Clinical Neurology
    https://thejcn.com/DOIx.php?id=10.3988/jcn.2020.16.3.376
    The current methods for detecting viral genomes solely by PCR using infected cells isolated from biofluids appear to be suboptimal or inefficient. […] Laboratory-based investigative biomedical research is urgently needed to accurately determine the underlying causes and mechanistic details of AFM.
  • #1
  • #1 Acute Flaccid Myelitis: Current Status and Diagnostic Challenges
    https://pmc.ncbi.nlm.nih.gov/articles/PMC7354978/
    Acute flaccid myelitis (AFM) is a sudden-onset polio-like neuromuscular disability found commonly in young children. There is an increasing incidence of confirmed AFM cases in the USA and other countries in recent years, and in association with nonpolio enterovirus infection. […] The incidence of AFM was first identified in the USA in 2014, and has steadily increased in 2019 to become recognized as a serious threat to public health. […] Up to 2019, there were 607 confirmed cases of AFM recorded out of many hundreds of reports from several states, with the incidence peaking in 2018. […] According to the World Health Organization, the surveillance of AFM cases is critically important to rule out the association of AFM with the polio vaccine in polio-free countries.
  • #1 Asthma Syndromic Surveillance for EV-D68 & acute flaccid myelitis (AFM) | Colorado Environmental Public Health Tracking
    https://coepht.colorado.gov/blog-post/asthma-syndromic-surveillance-for-ev-d68-acute-flaccid-myelitis-afm
    Acute flaccid myelitis (AFM) is a rare but serious condition that affects the nervous system, causing limb weakness and paralysis, mostly in children. […] While EV-D68 is thought to be a cause of AFM, current surveillance systems do not capture when, where, and to what extent EV-D68 is circulating, so preparing for increases in AFM is challenging. […] The model has not produced an alarm signal during an increase of COVID, RSV, or influenza. It has only alarmed during increased EV D68 circulation. […] This confirmation then allowed CHCO to activate its preparedness plan, which included increases in staffing schedules, securing the supply chain for asthma medications, and alerting providers to the possibility of cases of AFM. Ongoing asthma surveillance continued to help inform EV-D68 preparedness throughout August and September.
  • #1 Clinician Guidance for Acute Flaccid Myelitis (AFM) – Nevada Public Health | The Office of State Epidemiology
    https://nvose.org/clinician-guidance-for-acute-flaccid-myelitis-afm/
    As the winter season approaches, an increase in the circulation of respiratory pathogens, including enteroviruses, is expected. Enterovirus D-68 (EV-D68) is believed to be the main enterovirus responsible for the uncharacteristic increase in acute flaccid myelitis (AFM) cases observed during 2014, 2016, and 2018, which are referred to as peak years. […] Although there has been an increase in EV-D68 detections in the United States this year, the number of reported cases of AFM has remained relatively low, to date. […] As of November 1, 2024, the Centers for Disease Control and Prevention (CDC) has received 26 reports of suspected AFM, with 15 confirmed cases in 11 states. […] In past years, increases in EV-D68 respiratory disease have preceded cases of AFM by about 2 weeks. Therefore, vigilance for possible increases in EV-D68 respiratory disease and AFM is important.
  • #1
    https://www.nvhd.org/acute-flaccid-myelitis-afm/
    Most patients are children. […] The increase in AFM cases in 2014 coincided with a national outbreak of severe respiratory illness among people caused by enterovirus D68 (EV-D68). […] The cause of most of the AFM cases remains unknown. […] We dont know what caused the increase in AFM cases starting in 2014. […] We have not yet determined who is at higher risk for developing AFM, or the reasons why they may be at higher risk. […] We do not yet know the long-term effects of AFM.
  • #1 Acute Flaccid Myelitis – JETem
    https://jetem.org/acute-flaccid-myelitis/
    Although a somewhat rare disease, acute flaccid myelitis (AFM) can cause death, and for those pediatric patients that survive, less than 10% have full recovery. A cluster of cases that resembled polio was first described in California in 2012. After 120 cases of the disease were confirmed in 2014 in a 5-month period, the Centers for Disease Control and Prevention (CDC) began surveillance of the disease. Since surveillance began, clusters of cases have occurred in a biennial pattern, usually late summer and early fall. There were 218 cases between 2015 to 2017, 238 cases in 2018, 47 cases in 2019, and 32 in 2020. AFM has become recognized as a global disease with cases reported across many countries. The CDC has noted that the most common location of the first medical encounter of pediatric patients presenting with AFM is the emergency department in every year that surveillance occurred. Most of the children that are diagnosed with AFM are admitted to the hospital and of those admitted, 30% require intubation. Deaths related to AFM are due to respiratory involvement and complications. With appropriate recognition and supportive care, mortality can be avoided.
  • #2 Acute Flaccid Myelitis | AFM Surveillance | CDC
    http://medbox.iiab.me/modules/en-cdc/www.cdc.gov/acute-flaccid-myelitis/afm-surveillance.html
    CDC is concerned about AFM, a serious illness that we do not know all the cause of or how to prevent. […] CDC is actively investigating AFM cases. In 2016, 144 people in 37 states and DC were confirmed to have AFM. […] Even with an increase in cases in 2016, AFM remains a very rare disease (less than one in a million). […] Since August 2014, CDC has been made aware of an increased number of people across the United States with AFM for which no cause could be found. […] The increase in AFM cases in 2014 coincided with a national outbreak of severe respiratory illness among people caused by enterovirus D68 (EV-D68). […] Despite extensive testing, CDC does not yet know the cause of these AFM cases. […] CDC is actively investigating AFM cases and monitoring disease activity. […] CDC activities include: urging healthcare providers to be vigilant for AFM among their patients, and to send information about suspected cases to their health departments. […] CDC actively investigates the AFM cases, risk factors, and possible causes of this illness.
  • #2 About AFM | Acute Flaccid Myelitis Working Group
    https://acuteflaccidmyelitis.org/about-afm/
    AFM is a neurological condition characterized by a rapid onset of flaccid muscle weakness, with associated abnormalities on the radiological imaging of the spinal cord (MRI). […] Although sporadic cases of non-polio infantile paralysis have been reported in the medical literature in the past, it was not until 2012 in California and 2014 in Colorado when unusual but significant clusters of pediatric patients with a polio-like illness started rising quickly in the USA. This prompted the CDC to begin collecting surveillance data on the disease we now call AFM. Between August 2014 and June 2020, there have been 626 confirmed cases across the USA. AFM cases have also been reported in multiple regions worldwide including Canada, Europe, Asia, Australia, and South America. […] Thanks to the epidemiological surveillance efforts, it was noted that this disease usually follows a particular seasonal biennial pattern, with notable peaks of cases between August and October every 2 years (2014, 2016, 2018, and maybe 2020!). […] Over 90% of cases of AFM occur in children (median age of 6 years), and no racial or ethnic predispositions have been clearly identified. A slight predisposition to males has been reported.
  • #2 Acute Flaccid Myelitis (AFM) – MN Dept. of Health
    https://www.health.state.mn.us/diseases/afm/index.html
    Acute flaccid myelitis (AFM) is a rare but serious condition. CDC began tracking AFM in 2014. Since then, AFM cases have followed a seasonal and biennial pattern, spiking between August and October every other year. However, cases can occur year-round. […] Since surveillance for AFM began in 2014, Minnesota has seen between 0 and 11 cases per year. We work closely with health care providers and the Centers for Disease Control (CDC) to gather information on all cases. […] AFM cases confirmed by the CDC, Minnesota 2014-2023. […] Information for Health Professionals: Ongoing Surveillance for Acute Flaccid Myelitis Clinical guidance, surveillance, testing, and reporting information for health professionals.
  • #2 Acute flaccid myelitis – Wikipedia
    https://en.wikipedia.org/wiki/Acute_flaccid_myelitis
    Acute flaccid myelitis (AFM) is a serious condition of the spinal cord. The condition is rare and occurs most commonly in children. Fewer than one in 500,000 children is affected per year in the United States. Although the illness is not new, an increase in cases has been seen since 2014 in the United States. In 2018, 233 cases were confirmed in the United States. A seasonal pattern is seen in outbreaks, with a marked increase in cases reported in the late summer and early fall. The CDC has determined and submitted to GenBank complete or nearly complete genomic sequences for three known strains of the virus, which are „genetically related to strains of EV-D68 virus that were detected in previous years in the United States, Europe, and Asia.” While rates of paralytic symptoms appear to be correlated with the number of respiratory infections, in initial anecdotal reports, the cases are not clustered within a family or school, suggesting that the paralysis per se is not directly contagious, but arises as a very rare complication of the common respiratory infection. Cases of similar illnesses have been reported in Canada, Northern Europe, and Japan. Over 90% of reported cases are in children. CDC sees 2018 as a record year, annual documented cases of AFM reached a record 238 nationwide. The relatively lower circulation in 2020 may reflect the use of COVID-19 pandemic infection mitigation measures. Because of the EV-D68 surge in 2022 Health Alert Network (HAN) released a notice for Healthcare providers and hospitals. The CDC warned clinicians that EV-D68 detections have continued to be high. „Sentinel surveillance sites are reporting a higher proportion of EV-D68 positivity in children who are [rhinovirus and/or enterovirus] positive compared to previous years,” the agency wrote. Clinicians should be aware of „the potential for an increase in AFM cases in the upcoming weeks.” CDC urges healthcare providers to consider EV-D68 as a possible cause of acute, severe respiratory illness and a potential increase in AFM cases.
  • #2 CDC: Biennial Surge in Acute Flaccid Myelitis Has Come to a Halt | MedPage Today
    https://www.medpagetoday.com/infectiousdisease/generalinfectiousdisease/108563
    Acute flaccid myelitis (AFM) cases remained low in 2022, despite increased circulation of the enterovirus D68 (EV-D68) in the U.S., according to an analysis of CDC data. […] AFM cases ranged from 28 to 47 per year from 2019 to 2022 — far lower than the 238 confirmed cases in 2018, Sarah Kidd, MD, from the CDC’s National Center for Immunization and Respiratory Diseases in Atlanta, and colleagues reported in Morbidity and Mortality Weekly Report. […] As part of national surveillance of AFM, which began in 2014, U.S. health departments have submitted case reports of acute flaccid limb weakness with any spinal cord gray matter lesion on MRI to the CDC. […] AFM cases have tended to peak in even-numbered years, due to biennial outbreaks of EV-D68. […] It is unclear why EV-D68 circulation in 2022 was not associated with an increase in AFM cases or when the next increase in AFM cases will occur, wrote Kidd and co-authors.
  • #2 Acute Flaccid Myelitis | PM&R KnowledgeNow
    https://now.aapmr.org/acute-flaccid-myelitis/
    Acute Flaccid Myelitis (AFM) is a rapidly progressive immune and infectious mediated disease process that causes flaccid weakness of one or more limbs. […] AFM outbreaks occur every 2 years (since 2014) and primarily between the months of August and October. There were 120 cases reported in 2014, 149 cases in 2016, 238 cases in 2018, 47 in 2019, 33 in 2020, 28 in 2021 and 47 in 2022. […] Children represent over 90% of the reported AFM cases. […] There are no specific actions that have been identified to prevent AFM apart from decreasing risk of acquiring and spreading viral infections. […] 2019 and 2020 case numbers were more consistent with non-peak years, and it is possible that non-pharmacologic measures instituted against COVID 19 (ex. Masks, hand hygiene, physical distancing and virtual schooling) have helped decrease the spread of respiratory viruses including the Enterovirus class.
  • #2 Acute Flaccid Myelitis (AFM) | Health & Human Services
    https://hhs.iowa.gov/center-acute-disease-epidemiology/epi-manual/reportable-diseases/acute-flaccid-myelitis-afm
    This condition is not new, but the increase in cases we saw starting in 2014 is new. […] CDC estimates that less than one in a million people in the United States will get AFM every year. […] Most of the cases that CDC has learned about have been in children. […] Acute flaccid myelitis was first made temporarily reportable in January, 2016 and this order was reissued on October 15, 2018.
  • #2 Acute flaccid myelitis | Utah Epidemiology
    https://epi.utah.gov/acute-flaccid-myelitis/
    Acute flaccid myelitis (AFM) is a rare but serious condition that affects the spinal cord. It can cause muscle weakness that comes on suddenly and can sometimes result in permanent paralysis. Most people who have AFM experience sudden onset of weakness in 1 or more limbs and/or a loss of muscle tone and reflexes. Some people with AFM also have trouble moving their eyes or have drooping eyelids, facial weakness or droop, difficulty swallowing or slurred speech, pain in the arms or legs, and/or pain in the neck or back. AFM most commonly affects children, and does not spread person to person. […] The exact cause of AFM is still unknown. AFM happens most often after someone is infected with a virus (enterovirus) that starts in the stomach or intestines and works its way to the brain and spinal cord. Enteroviruses are very common and usually don’t cause symptoms at all or very mild flu-like symptoms. Poliovirus is a type of enterovirus. Other causes of AFM may include environmental toxins or genetic disorders, but these are still being researched. […] Acute Flaccid Myelitis in the United States—August – December 2014: Results of Nation-Wide Surveillance.
  • #2 Acute Flaccid Myelitis (AFM) – HAN
    https://www.chicagohan.org/diseases-and-conditions/afm
    In 2021, the CDC updated the AFM case definition, which is used to ensure consistent and accurate case classification for surveillance purposes. All patients under investigation for AFM will receive final classification by a team of expert neurologists. […] Clinicians should continue to be vigilant and send information to Chicago Department of Public Health (CDPH) for all patients under investigation (PUI) with sudden onset of neurologic illness associated with limb weakness that meet the case definition for Acute Flaccid Myelitis.
  • #2 :: JCN :: Journal of Clinical Neurology
    https://thejcn.com/DOIx.php?id=10.3988/jcn.2020.16.3.376
    Acute flaccid myelitis (AFM) is a sudden-onset polio-like neuromuscular disability found commonly in young children. […] There is an increasing incidence of confirmed AFM cases in the USA and other countries in recent years, and in association with nonpolio enterovirus infection. […] The incidence of AFM was first identified in the USA in 2014, and has steadily increased in 2019 to become recognized as a serious threat to public health. […] Up to 2019, there were 607 confirmed cases of AFM recorded out of many hundreds of reports from several states, with the incidence peaking in 2018. […] According to the World Health Organization, the surveillance of AFM cases is critically important to rule out the association of AFM with the polio vaccine in polio-free countries. […] It might be necessary to design novel alternative or degenerate primers to amplify unknown sequences from mutant variants associated with AFM pathogenesis.
  • #2 Health Alert: Acute Flaccid Myelitis
    https://www.snohd.org/CivicSend/ViewMessage/message/183540
    Since the end of August 2022, CDC sentinel surveillance sites for respiratory pathogens have been reporting increases in enterovirus D-68 (EV-D68) respiratory disease. EV-D68 is also the main enterovirus responsible for cases of acute flaccid myelitis (AFM) during years when we see increases in AFM cases. AFM is a rare outcome of EV-D68 infection and is a serious neurologic condition that affects mostly children. It typically presents with sudden limb weakness that can lead to permanent paralysis. Traditionally, increases in EV-D68 respiratory disease have preceded cases of AFM by about 2 weeks. Therefore, increased vigilance for AFM is important. […] Recent respiratory illness or fever and the presence of neck or back pain or any neurologic symptom should heighten suspicion for AFM. […] Case reporting will help states and CDC monitor AFM and better understand factors associated with this illness.
  • #2 Acute flaccid myelitis (AFM) in Canada, 2018 to 2019, CCDR 46(10) – Canada.ca
    https://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2020-46/issue-10-october-1-2020/acute-flaccid-myelitis.html
    Starting in 2014, biennial clusters of acute flaccid myelitis (AFM), frequently described as polio-like illness, have been reported across the United States and elsewhere, often linked to enteroviruses. […] To assess AFM trends in Canada, we reviewed the Canadian Acute Flaccid Paralysis Surveillance System (CAFPSS) for cases reported during the 2018 and 2019 calendar years that meet the Centers for Disease Control and Prevention case definitions for AFM. […] At the time of writing this report, 2020 AFM data were not yet available; it is unknown if a spike in AFM cases will be seen in 2020. […] The seriousness of the condition as well as the lack of clear knowledge about the etiology of the disease underscore the need to better understand the epidemiology of AFM to further identify prevention and patient management measures.